Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Can J Psychiatry

Retrieve available abstracts of 47 articles:
HTML format

Single Articles

    May 2022
  1. DO A, Li VW, Huang S, Michalak EE, et al
    Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Can J Psychiatry. 2022 May 6:7067437221097903. doi: 10.1177/07067437221097903.
    PubMed     Abstract available

  2. BONARDI O, Wang Y, Li K, Jiang X, et al
    Effects of COVID-19 Mental Health Interventions Among Children, Adolescents, and Adults Not Quarantined or Undergoing Treatment Due to COVID-19 Infection: A Systematic Review of Randomised Controlled Trials.
    Can J Psychiatry. 2022;67:336-350.
    PubMed     Abstract available

  3. GOEGAN SA, Hasey GM, King JP, Losier BJ, et al
    Naturalistic Study on the Effects of Electroconvulsive Therapy (ECT) on Depressive Symptoms.
    Can J Psychiatry. 2022;67:351-360.
    PubMed     Abstract available

    April 2022
  4. DIEP C, Bhat V, Wijeysundera DN, Clarke HA, et al
    The Association between Recent Cannabis Use and Suicidal Ideation in Adults: A Population-based Analysis of the NHANES from 2005 to 2018.
    Can J Psychiatry. 2022;67:259-267.
    PubMed     Abstract available

    March 2022
  5. VASILIADIS HM, Lamoureux-Lamarche C, Grenier S, Roberge P, et al
    Minimally Adequate Treatment for Depression and Anxiety Associated With Mortality in Primary Care Older Adults.
    Can J Psychiatry. 2022 Mar 7:7067437221082883. doi: 10.1177/07067437221082883.
    PubMed     Abstract available

  6. XI C, Liu Z, Zeng C, Tan W, et al
    The centrality of working memory networks in differentiating bipolar type I depression from unipolar depression: A task-fMRI study.
    Can J Psychiatry. 2022 Mar 4:7067437221078646. doi: 10.1177/07067437221078646.
    PubMed     Abstract available

    January 2022
  7. VAN LIESHOUT RJ, Layton H, Savoy CD, Haber E, et al
    Public Health Nurse-delivered Group Cognitive Behavioural Therapy for Postpartum Depression: A Randomized Controlled Trial.
    Can J Psychiatry. 2022 Jan 21:7067437221074426. doi: 10.1177/07067437221074426.
    PubMed     Abstract available

  8. BENOIT JRA, Dursun SM, Greiner R, Cao B, et al
    Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine.
    Can J Psychiatry. 2022;67:39-47.
    PubMed     Abstract available

    November 2021
  9. SAREEN J, Bolton SL, Mota N, Afifi TO, et al
    Lifetime Prevalence and Comorbidity of Mental Disorders in the Two-wave 2002-2018 Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS): Prevalence et Comorbidite de Duree de vie Des Troubles Mentaux Dans l'Enquete de Sui
    Can J Psychiatry. 2021;66:951-960.
    PubMed     Abstract available

  10. AFIFI TO, Sareen J, Taillieu T, Stewart-Tufescu A, et al
    Association of Child Maltreatment and Deployment-related Traumatic Experiences with Mental Disorders in Active Duty Service Members and Veterans of the Canadian Armed Forces: Association de la Maltraitance des Enfants et des Experiences Traumatisantes
    Can J Psychiatry. 2021;66:961-970.
    PubMed     Abstract available

    October 2021
  11. SARRIS J, Marx W, Ashton MM, Ng CH, et al
    Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les medicaments a base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une me
    Can J Psychiatry. 2021;66:849-862.
    PubMed     Abstract available

    September 2021
  12. BULLOCH A, Zulyniak S, Williams J, Bajgai J, et al
    Poor Mental Health during the COVD-19 Pandemic: Effect Modification by Age.
    Can J Psychiatry. 2021;66:827-829.

  13. MCINERNEY SJ, Chakrabarty T, Maciukiewicz M, Frey BN, et al
    Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Pro
    Can J Psychiatry. 2021;66:798-806.
    PubMed     Abstract available

    June 2021
  14. WONG SMY, Hui CLM, Wong CSM, Suen YN, et al
    Mental Health Risks after Repeated Exposure to Multiple Stressful Events during Ongoing Social Unrest and Pandemic in Hong Kong: The Role of Rumination: Risques pour la sante mentale apres une exposition repetee a de multiples evenements stressants d'
    Can J Psychiatry. 2021;66:577-585.
    PubMed     Abstract available

    Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder.
    Can J Psychiatry. 2021;66:537-539.

    April 2021
  16. VAIDYAM AN, Linggonegoro D, Torous J
    Changes to the Psychiatric Chatbot Landscape: A Systematic Review of Conversational Agents in Serious Mental Illness: Changements du paysage psychiatrique des chatbots: une revue systematique des agents conversationnels dans la maladie mentale serieus
    Can J Psychiatry. 2021;66:339-348.
    PubMed     Abstract available

    March 2021
  17. MORTON E, Michalak EE, Levitt A, Levitan RD, et al
    Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Can J Psychiatry. 2021;66:289-297.
    PubMed     Abstract available

    February 2021
  18. SWAINSON J, McGirr A, Blier P, Brietzke E, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Reseau Canadien Pour Les Traitements De L'humeur
    Can J Psychiatry. 2021;66:113-125.
    PubMed     Abstract available

  19. BHARGAV PH, Reddy PV, Govindaraj R, Gulati K, et al
    Impact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial.
    Can J Psychiatry. 2021;66:179-181.

  20. BARTOLI F, Bachi B, Calabrese A, Moretti F, et al
    Cannabidiol for Mood Disorders: A Call for More Research.
    Can J Psychiatry. 2021;66:182-183.

    January 2021
  21. ENNS MW, Mota N, Afifi TO, Bolton SL, et al
    Course and Predictors of Major Depressive Disorder in the Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey: Cours et Predicteurs du Trouble de Depression Majeure Dans l'Enquete de Suivi Sur la Sante Mentale Aupres Des Membres
    Can J Psychiatry. 2021 Jan 7:706743720984677. doi: 10.1177/0706743720984677.
    PubMed     Abstract available

  22. LEMIEUX R, Garon-Bissonnette J, Loiselle M, Martel E, et al

    Can J Psychiatry. 2021;66:34-42.
    PubMed     Abstract available

  23. SMITH PM, Oudyk J, Potter G, Mustard C, et al
    The Association between the Perceived Adequacy of Workplace Infection Control Procedures and Personal Protective Equipment with Mental Health Symptoms: A Cross-sectional Survey of Canadian Health-care Workers during the COVID-19 Pandemic: L'associatio
    Can J Psychiatry. 2021;66:17-24.
    PubMed     Abstract available

  24. MURRAY G, Gottlieb J, Swartz HA
    Maintaining Daily Routines to Stabilize Mood: Theory, Data, and Potential Intervention for Circadian Consequences of COVID-19.
    Can J Psychiatry. 2021;66:9-13.

    November 2020
  25. LI A, Rosella LC, Kurdyak P, Wodchis WP, et al
    Depression as a Risk Factor for Physical Illness and Multimorbidity in a Cohort with No Prior Comorbidity: La Depression Comme Facteur de Risque de Maladie Physique et de Multimorbidite Dans Une Cohorte Sans Comorbidite Anterieure.
    Can J Psychiatry. 2020 Nov 26:706743720974832. doi: 10.1177/0706743720974832.
    PubMed     Abstract available

  26. BAHJI A, Ermacora D, Stephenson C, Hawken ER, et al
    Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis: Efficacite Et Tolerabilite Comparatives Des Pharmacotherapies D'appoint Pour La Depression Bipolaire Aig
    Can J Psychiatry. 2020 Nov 11:706743720970857. doi: 10.1177/0706743720970857.
    PubMed     Abstract available

    October 2020
  27. THOMBS BD, Levis B, Lyubenova A, Neupane D, et al
    Overestimation of Postpartum Depression Prevalence Based on a 5-item Version of the EPDS: Systematic Review and Individual Participant Data Meta-analysis.
    Can J Psychiatry. 2020 Oct 26:706743720934959. doi: 10.1177/0706743720934959.
    PubMed     Abstract available

  28. SCHMITZ N, Holley P, Meng X, Fish L, et al
    COVID-19 and Depressive Symptoms: A Community-based Study in Quebec, Canada.
    Can J Psychiatry. 2020;65:733-735.

  29. ZHOU L, Xie RH, Yang X, Zhang S, et al
    Feasibility and Preliminary Results of Effectiveness of Social Media-based Intervention on the Psychological Well-being of Suspected COVID-19 Cases during Quarantine.
    Can J Psychiatry. 2020;65:736-738.

    August 2020
  30. YANG YB, Chan P, Rayani K, McGirr A, et al
    Comparative Effectiveness of Repetitive Transcranial Magnetic Stimulation in Unipolar and Bipolar Depression.
    Can J Psychiatry. 2020 Aug 20:706743720950938. doi: 10.1177/0706743720950938.

    July 2020
  31. RAVINDRAN AV, McKay MS, da Silva T, Tindall C, et al
    Breathing-focused Yoga as Augmentation for Unipolar and Bipolar Depression: A Randomized Controlled Trial: Le yoga axe sur la respiration comme traitement d'appoint pour la depression unipolaire et bipolaire: Un essai randomise controle.
    Can J Psychiatry. 2020 Jul 17:706743720940535. doi: 10.1177/0706743720940535.
    PubMed     Abstract available

  32. KASTER TS, Blumberger DM, Gomes T, Sutradhar R, et al
    Patient-level Characteristics and Inequitable Access to Inpatient Electroconvulsive Therapy for Depression: A Population-based Cross-sectional Study: Caracteristiques au niveau du patient et acces inequitable a la therapie electroconvulsive pour patie
    Can J Psychiatry. 2020 Jul 2:706743720935647. doi: 10.1177/0706743720935647.
    PubMed     Abstract available

    June 2020
  33. CASTELLI L, Di Tella M, Benfante A, Romeo A, et al
    The Spread of COVID-19 in the Italian Population: Anxiety, Depression, and Post-traumatic Stress Symptoms.
    Can J Psychiatry. 2020 Jun 26:706743720938598. doi: 10.1177/0706743720938598.

  34. COURTNEY D, Watson P, Battaglia M, Mulsant BH, et al
    COVID-19 Impacts on Child and Youth Anxiety and Depression: Challenges and Opportunities.
    Can J Psychiatry. 2020 Jun 22:706743720935646. doi: 10.1177/0706743720935646.

    May 2020
  35. CHIU M, Saxena FE, Kurdyak P, Wilton AS, et al
    Health Service Use among Individuals with Depression and Psychological Distress: A Population-Based Cohort Study in Ontario, Canada.
    Can J Psychiatry. 2020 May 27:706743720927826. doi: 10.1177/0706743720927826.
    PubMed     Abstract available

  36. WALL-WIELER E, Robakis TK, Cesta CE, Masarwa R, et al
    Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy.
    Can J Psychiatry. 2020 May 21:706743720927829. doi: 10.1177/0706743720927829.
    PubMed     Abstract available

  37. ONAEMO VN, Fawehinmi TO, D'Arcy C
    Alcohol Use Disorder and the Persistence/Recurrence of Major Depression.
    Can J Psychiatry. 2020 May 4:706743720923065. doi: 10.1177/0706743720923065.
    PubMed     Abstract available

    March 2020
  38. SETO MC, Rodrigues NC, Ham E, Kirsh B, et al
    Post-traumatic Stress Disorder, Depression, Anxiety Symptoms and Help Seeking in Psychiatric Staff.
    Can J Psychiatry. 2020 Mar 31:706743720916356. doi: 10.1177/0706743720916356.
    PubMed     Abstract available

    January 2020
  39. KLEIN DN
    Persistent Depressive Disorder: Commentary on Parker and Malhi.
    Can J Psychiatry. 2020;65:16-18.

    December 2019
  40. TANNER JA, Hensel J, Davies PE, Brown LC, et al
    Economic Burden of Depression and Associated Resource Use in Manitoba, Canada.
    Can J Psychiatry. 2019 Dec 13:706743719895342. doi: 10.1177/0706743719895342.
    PubMed     Abstract available

  41. LAM RW, Teng MY, Jung YE, Evans VC, et al
    Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Can J Psychiatry. 2019 Dec 12:706743719892471. doi: 10.1177/0706743719892471.
    PubMed     Abstract available

  42. GOLDBLOOM DS, Gratzer D
    Barriers to Brain Stimulation Therapies for Treatment-Resistant Depression: Beyond Cost Effectiveness.
    Can J Psychiatry. 2019 Dec 9:706743719893584. doi: 10.1177/0706743719893584.

  43. FITZGIBBON KP, Plett D, Chan BCF, Hancock-Howard R, et al
    Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
    Can J Psychiatry. 2019 Dec 5:706743719890167. doi: 10.1177/0706743719890167.
    PubMed     Abstract available

    November 2019
  44. ASHTON MM, Mohebbi M, Turner A, Marx W, et al
    Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial.
    Can J Psychiatry. 2019 Nov 28:706743719889547. doi: 10.1177/0706743719889547.
    PubMed     Abstract available

    May 2019
    Cannabis and Mental Health: Insights from Canadian Research.
    Can J Psychiatry. 2019;64:302-303.

    January 2019
  46. LEUZINGER-BOHLEBER M, Hautzinger M, Fiedler G, Keller W, et al
    Outcome of Psychoanalytic and Cognitive-Behavioural Long-Term Therapy with Chronically Depressed Patients: A Controlled Trial with Preferential and Randomized Allocation.
    Can J Psychiatry. 2019;64:47-58.
    PubMed     Abstract available

  47. THERIAULT FL, Garber BG, Momoli F, Gardner W, et al
    Mental Health Service Utilization in Depressed Canadian Armed Forces Personnel.
    Can J Psychiatry. 2019;64:59-67.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.